| Long-lasting stem cell–like memory CD8+ T cells with a naïve-like profile upon yellow fever vaccination SA Fuertes Marraco, C Soneson, L Cagnon, PO Gannon, M Allard, ... Science translational medicine 7 (282), 282ra48-282ra48, 2015 | 204 | 2015 |
| Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients D Migliorini, V Dutoit, M Allard, N Grandjean Hallez, E Marinari, V Widmer, ... Neuro-oncology 21 (7), 923-933, 2019 | 109 | 2019 |
| Identifying individual T cell receptors of optimal avidity for tumor antigens M Hebeisen, M Allard, PO Gannon, J Schmidt, DE Speiser, N Rufer Frontiers in immunology 6, 582, 2015 | 92 | 2015 |
| Peptides as cancer vaccines MC Tardón, M Allard, V Dutoit, PY Dietrich, PR Walker Current opinion in pharmacology 47, 20-26, 2019 | 87 | 2019 |
| Serum soluble HLA-E in melanoma: a new potential immune-related marker in cancer M Allard, R Oger, V Vignard, JM Percier, G Fregni, A Périer, A Caignard, ... PLoS One 6 (6), e21118, 2011 | 86 | 2011 |
| Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by ChemotherapyNK Cell Activation in Metastatic Melanoma G Fregni, A Perier, G Pittari, S Jacobelli, X Sastre, N Gervois, M Allard, ... Clinical Cancer Research 17 (9), 2628-2637, 2011 | 61 | 2011 |
| Fine-tuning of optimal TCR signaling in tumor-redirected CD8 T cells by distinct TCR affinity-mediated mechanisms D Presotto, E Erdes, MN Duong, M Allard, PO Regamey, M Quadroni, ... Frontiers in immunology 8, 1564, 2017 | 48 | 2017 |
| TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency M Allard, B Couturaud, L Carretero-Iglesia, MN Duong, J Schmidt, ... JCI insight 2 (14), 2017 | 48 | 2017 |
| HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition N Jouand, C Bressollette-Bodin, N Gérard, M Giral, P Guérif, A Rodallec, ... PLoS pathogens 14 (4), e1007041, 2018 | 38 | 2018 |
| Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma A Perier, G Fregni, S Wittnebel, S Gad, M Allard, N Gervois, B Escudier, ... Oncogene 30 (23), 2622-2632, 2011 | 37 | 2011 |
| HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation M Allard, P Tonnerre, S Nedellec, R Oger, A Morice, Y Guilloux, ... PloS one 7 (11), e50951, 2012 | 35 | 2012 |
| IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4+CD8+ double‐positive T cells T Parrot, M Allard, R Oger, H Benlalam, D Raingeard de la Blétière, ... European Journal of Immunology 46 (7), 1770-1782, 2016 | 33 | 2016 |
| Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade glioma E Marinari, M Allard, R Gustave, V Widmer, G Philippin, D Merkler, ... Oncoimmunology 9 (1), 1779990, 2020 | 32 | 2020 |
| Quantitative TCR: pMHC dissociation rate assessment by NTAmers reveals antimelanoma T cell repertoires enriched for high functional competence PO Gannon, S Wieckowski, P Baumgaertner, M Hebeisen, M Allard, ... The Journal of Immunology 195 (1), 356-366, 2015 | 24 | 2015 |
| Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules M Allard, R Oger, H Benlalam, L Florenceau, K Echasserieau, ... The Journal of Immunology 192 (11), 5090-5097, 2014 | 24 | 2014 |
| Raingeard de la Bletiere D, Coutolleau A, et al T Parrot, M Allard, R Oger, H Benlalam IL-9 promotes the survival and function of human melanoma-infiltrating CD4 …, 2016 | 23 | 2016 |
| Genome-wide RNA profiling of long-lasting stem cell-like memory CD8 T cells induced by Yellow Fever vaccination in humans SAF Marraco, C Soneson, M Delorenzi, DE Speiser Genomics data 5, 297-301, 2015 | 19 | 2015 |
| Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cells L Seguin, S Odouard, F Corlazzoli, SA Haddad, L Moindrot, ... Communications biology 4 (1), 1-17, 2021 | 16 | 2021 |
| Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma T Parrot, R Oger, M Allard, J Desfrançois, D Raingeard de la Blétière, ... Scientific reports 10 (1), 1-9, 2020 | 16 | 2020 |
| Heterogeneity assessment of functional T cell avidity K Ioannidou, P Baumgaertner, PO Gannon, MF Speiser, M Allard, ... Scientific reports 7 (1), 1-11, 2017 | 14 | 2017 |
